NO20004383L - Acylbenzoksaziner til forbedring av synaptisk respons - Google Patents

Acylbenzoksaziner til forbedring av synaptisk respons

Info

Publication number
NO20004383L
NO20004383L NO20004383A NO20004383A NO20004383L NO 20004383 L NO20004383 L NO 20004383L NO 20004383 A NO20004383 A NO 20004383A NO 20004383 A NO20004383 A NO 20004383A NO 20004383 L NO20004383 L NO 20004383L
Authority
NO
Norway
Prior art keywords
ampa receptors
treatment
methods
acylbenzoxazines
impaired
Prior art date
Application number
NO20004383A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004383D0 (no
Inventor
Gary A Rogers
Peter Johnstroem
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO20004383D0 publication Critical patent/NO20004383D0/no
Publication of NO20004383L publication Critical patent/NO20004383L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20004383A 1998-04-03 2000-09-04 Acylbenzoksaziner til forbedring av synaptisk respons NO20004383L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,916 US6124278A (en) 1998-04-03 1998-04-03 Acylbenzoxazines for enhancing synaptic response
PCT/US1999/007325 WO1999051240A1 (fr) 1998-04-03 1999-04-02 Acylbenzoxazines utiles pour ameliorer une/des reaction(s) synaptique(s)

Publications (2)

Publication Number Publication Date
NO20004383D0 NO20004383D0 (no) 2000-09-04
NO20004383L true NO20004383L (no) 2000-10-09

Family

ID=21994357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004383A NO20004383L (no) 1998-04-03 2000-09-04 Acylbenzoksaziner til forbedring av synaptisk respons

Country Status (22)

Country Link
US (1) US6124278A (fr)
EP (1) EP1067935B1 (fr)
JP (1) JP4574846B2 (fr)
KR (1) KR100646753B1 (fr)
CN (1) CN1186020C (fr)
AT (1) ATE247472T1 (fr)
BR (1) BR9909378A (fr)
CA (1) CA2326764C (fr)
CZ (1) CZ292931B6 (fr)
DE (1) DE69910552T2 (fr)
DK (1) DK1067935T3 (fr)
ES (1) ES2207194T3 (fr)
HK (1) HK1039060B (fr)
HU (1) HUP0102321A3 (fr)
IL (1) IL138284A0 (fr)
NO (1) NO20004383L (fr)
NZ (1) NZ506712A (fr)
PL (1) PL195394B1 (fr)
PT (1) PT1067935E (fr)
RU (1) RU2246498C2 (fr)
TR (1) TR200002849T2 (fr)
WO (1) WO1999051240A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
IL158928A0 (en) 2001-06-14 2004-05-12 Akzo Nobel Nv (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES
SK2292004A3 (en) * 2001-11-26 2004-09-08 Cortex Pharma Inc Carbonyl benzoxazine compounds for enhancement of glutamatergic synaptic responses
US20110104716A1 (en) * 2003-08-08 2011-05-05 Hasan Mohejeri Novel method for screening brain-active compounds
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
NZ589671A (en) * 2008-06-06 2012-03-30 Sanofi Aventis Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
EP3311842A1 (fr) 2013-06-13 2018-04-25 VeroScience LLC Compositions et procédés de traitement des troubles métaboliques
CN108689876B (zh) * 2018-06-28 2020-11-27 苏州东南药业股份有限公司 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475908A1 (fr) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Composés lactames chromogènes, leur préparation et leur utilisation
DE69331761T2 (de) * 1992-07-24 2002-09-12 The Regents Of The University Of California, Oakland Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response

Also Published As

Publication number Publication date
RU2246498C2 (ru) 2005-02-20
ES2207194T3 (es) 2004-05-16
NO20004383D0 (no) 2000-09-04
IL138284A0 (en) 2001-10-31
PT1067935E (pt) 2004-01-30
HK1039060A1 (en) 2002-04-12
CN1306427A (zh) 2001-08-01
CZ20003614A3 (cs) 2001-01-17
HUP0102321A2 (hu) 2001-11-28
DE69910552T2 (de) 2004-06-17
CN1186020C (zh) 2005-01-26
PL345687A1 (en) 2002-01-02
BR9909378A (pt) 2000-12-05
ATE247472T1 (de) 2003-09-15
WO1999051240A8 (fr) 2001-03-22
US6124278A (en) 2000-09-26
PL195394B1 (pl) 2007-09-28
HUP0102321A3 (en) 2002-01-28
CZ292931B6 (cs) 2004-01-14
EP1067935B1 (fr) 2003-08-20
AU736376B2 (en) 2001-07-26
EP1067935A4 (fr) 2001-10-04
HK1039060B (zh) 2005-05-13
NZ506712A (en) 2002-11-26
KR100646753B1 (ko) 2006-11-17
DE69910552D1 (de) 2003-09-25
EP1067935A1 (fr) 2001-01-17
AU3379899A (en) 1999-10-25
WO1999051240A1 (fr) 1999-10-14
JP2002510635A (ja) 2002-04-09
KR20010042192A (ko) 2001-05-25
JP4574846B2 (ja) 2010-11-04
TR200002849T2 (tr) 2001-06-21
CA2326764C (fr) 2010-12-14
CA2326764A1 (fr) 1999-10-14
DK1067935T3 (da) 2003-11-24

Similar Documents

Publication Publication Date Title
AU2427497A (en) Benzoxazines for enhancing synaptic response
PT839134E (pt) Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica
CA2138533A1 (fr) Medicaments ameliorant les reponses de synapses, utilisant des recepteurs ampa
NO20003166L (no) Benzoksazin-forbindelser for forandring av synaptisk respons
NO20004383L (no) Acylbenzoksaziner til forbedring av synaptisk respons
NO20013003L (no) Kinolin-derivater
DE69425267D1 (de) 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
DE60027769D1 (de) Pyrrolidin-derivate als inhibitoren von cyclischer amp-phosphodiesterase
NO306779B1 (no) Naftalamider, anvendelse derav og farmasöytisk preparat
NO993768D0 (no) Benzofuranforbindelser med AMPA reseptor aktivitet
EA200400584A1 (ru) Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application